{"id":446448,"date":"2021-02-26T22:53:21","date_gmt":"2021-02-27T03:53:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=446448"},"modified":"2021-02-26T22:53:21","modified_gmt":"2021-02-27T03:53:21","slug":"biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/","title":{"rendered":"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW ORLEANS<\/span>, Feb. 26, 2021<\/span> \/PRNewswire\/ — Former Attorney General of Louisiana<\/span>, Charles C. Foti, Jr., Esq.<\/span>, a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). \u00a0<\/p>\n

\n

\n
\n \"Kahn
\n <\/a>\n <\/p>\n<\/p><\/div>\n

On August 19, 2020<\/span>, the Company disclosed that it received a Complete Response Letter (“CRL”) from the FDA rejecting its Biologics License Application (“BLA”) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company’s ongoing 270-301 study (Phase 3) and that the Company “complete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants,” thus requiring a lengthier study before approval would be considered.<\/p>\n

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing. <\/p>\n

KSF’s investigation is focusing on whether BioMarin’s officers and\/or directors breached their fiduciary duties to BioMarin’s shareholders or otherwise violated state or federal laws.\u00a0 <\/p>\n

If you have information that would assist KSF in its investigation, or have been a long-term holder of BioMarin shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com<\/a>), or visit https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-bmrn\/<\/a> to learn more.<\/p>\n

About Kahn Swick & Foti, LLC<\/p>\n

KSF, whose partners include former Louisiana<\/span> Attorney General Charles C. Foti, Jr.<\/span>, is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients \u2013 including public institutional investors, hedge funds, money managers and retail investors \u2013 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York<\/span>, California<\/span> and Louisiana<\/span>.<\/p>\n

To learn more about KSF, you may visit www.ksfcounsel.com<\/a>.<\/p>\n

Contact:<\/p>\n

Kahn Swick & Foti, LLC
Lewis Kahn<\/span>, Managing Partner
lewis.kahn@ksfcounsel.com<\/a>
<\/u>1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA<\/span> 70163<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/biomarin-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc—bmrn-301236793.html<\/a><\/p>\n

SOURCE Kahn Swick & Foti, LLC<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW ORLEANS, Feb. 26, 2021 \/PRNewswire\/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). \u00a0 On August 19, 2020, the Company disclosed that it received a Complete Response Letter (“CRL”) from the FDA rejecting its Biologics License Application (“BLA”) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company’s ongoing 270-301 study (Phase 3) and that the Company “complete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants,” thus requiring a lengthier study before approval would be considered. … <\/p>\n

Continue reading “BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-446448","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW ORLEANS, Feb. 26, 2021 \/PRNewswire\/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). \u00a0 On August 19, 2020, the Company disclosed that it received a Complete Response Letter (“CRL”) from the FDA rejecting its Biologics License Application (“BLA”) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company’s ongoing 270-301 study (Phase 3) and that the Company “complete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants,” thus requiring a lengthier study before approval would be considered. … Continue reading "BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-27T03:53:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN\",\"datePublished\":\"2021-02-27T03:53:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/\"},\"wordCount\":385,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/\",\"name\":\"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"datePublished\":\"2021-02-27T03:53:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/","og_locale":"en_US","og_type":"article","og_title":"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","og_description":"PR Newswire NEW ORLEANS, Feb. 26, 2021 \/PRNewswire\/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). \u00a0 On August 19, 2020, the Company disclosed that it received a Complete Response Letter (“CRL”) from the FDA rejecting its Biologics License Application (“BLA”) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company’s ongoing 270-301 study (Phase 3) and that the Company “complete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants,” thus requiring a lengthier study before approval would be considered. … Continue reading \"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-27T03:53:21+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN","datePublished":"2021-02-27T03:53:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/"},"wordCount":385,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/","name":"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","datePublished":"2021-02-27T03:53:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=446448"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446448\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=446448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=446448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=446448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}